| 000 | 01894 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514002637.0 | ||
| 264 | 0 | _c20010712 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/s002620100185 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Paoli, P | |
| 245 | 0 | 0 |
_aLymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cMay 2001 |
||
| 300 |
_a157-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD19 _xbiosynthesis |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aHIV _xmetabolism |
| 650 | 0 | 4 |
_aHIV Seropositivity _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xvirology |
| 650 | 0 | 4 |
_aLymphocyte Subsets _xmetabolism |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aVaccher, E | |
| 700 | 1 | _aTedeschi, R | |
| 700 | 1 | _aCaffau, C | |
| 700 | 1 | _aZanussi, S | |
| 700 | 1 | _aBortolin, M T | |
| 700 | 1 | _aCrepaldi, C | |
| 700 | 1 | _aSpina, M | |
| 700 | 1 | _aTirelli, U | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 50 _gno. 3 _gp. 157-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002620100185 _zAvailable from publisher's website |
| 999 |
_c11348910 _d11348910 |
||